The global antiviral drugs market size is expected to reach USD 91.21 Billion in 2028 and register a revenue CAGR of 4.8% over the forecast period, according to a latest report by Reports and Data. Development of generic antiviral drugs, coupled with increasing prevalence of viral infections such as HIV, influenza, and herpes simplex virus are major factors expected to drive market revenue growth during the forecast period. As per the World Health Organization (WHO), an estimated 354 Million people worldwide are suffering from Hepatitis B or C, and for most people, testing and treatment remain beyond reach. Governments across the world are increasingly providing funds to pharmaceutical companies in order to provide affordable treatment to patients and curb the spread of viral infections.

An estimated 4.5 Million premature deaths could be prevented in low- and middle- income countries by 2030 through vaccination, diagnostic tests, medicines, and education campaigns. Global hepatitis strategy by WHO aims to reduce new hepatitis infections by 90% and deaths by 65% between 2016 and 2030. Increasing number of such initiatives by government and healthcare organizations in various countries across the globe are factors expected to boost revenue growth of the market during the forecast period. Improvement in clinical outcome and growing use of generic antiviral drugs are further supporting revenue growth of the market. Pharmaceutical companies are investing in development of cost-effective generic drugs which can meet same strength, purity standards, and quality as that of branded drugs. Companies such as Aurobindo Pharma Limited, Cipla Limited, and Dr. Reddy's Laboratories are focusing on launching effective generic antiviral drugs.  

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1734

The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.

Key companies operating in the market include:

Gilead Sciences, F. Hoffmann-La Roche AG, GlaxoSmithKline, Bristol-Myers-Squibb, AbbVie, Johnson Johnson, Merck Co., Aurobindo Pharma, Cipla, and Dr Reddy’s

The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.

The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Antiviral Drugs  market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.

On basis of product types and application offered by the Antiviral Drugs  industry, the market is segmented into:

Type (Revenue, USD Million; 2018–2028)

• Branded
• Generic

Application (Revenue, USD Million; 2018–2028)

• HIV
• Hepatitis
• Herpes Simplex Virus
• Influenza
• Others

Mechanism of Action (Revenue, USD Million; 2018–2028)

• Reverse transcriptase inhibitors
• Nucleotide polymerase inhibitors
• Protease inhibitors
• Others

The regional analysis covers:

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Italy
  • France
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East Africa
  • Saudi Arabia
  • A.E.
  • South Africa
  • Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/antiviral-drugs-market

Key Features of the Global Antiviral Drugs  Market Report:

• Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
• Identification and analysis of significant trends and factors driving revenue growth of the market
• Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
• Assessment of each market segment along with their growth trends and market revenue contribution
• Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1734

Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.